MedPath

MERZ PHARMACEUTICALS GMBH

MERZ PHARMACEUTICALS GMBH logo
🇺🇸United States
Ownership
Subsidiary
Established
1908-01-01
Employees
101
Market Cap
-
Website
https://www.radiesse.de

Neramexane for Tinnitus

Phase 2
Completed
Conditions
Tinnitus
Interventions
Drug: Placebo
Drug: Neramexane
First Posted Date
2006-11-30
Last Posted Date
2011-03-11
Lead Sponsor
Merz Pharmaceuticals GmbH
Target Recruit Count
431
Registration Number
NCT00405886
© Copyright 2025. All Rights Reserved by MedPath